Evidence Based Use of T3+T4 Combinations, Symposium

Leading clinicians from across the world are coming together for a  Joint Symposium on evidence based use of T3+T4 combinations for treating hypothyroidism.

The event will take place on Sunday 3rd November 2019, in both London and Chicago, with participants in both locations sharing information and debate.

It has been jointly organised by the American Thyroid Association® (ATA®), the British Thyroid Association (BTA) and the European Thyroid Association (ETA).

This is a professional event aimed at raising awareness, amongst clinicians, of the evidence base for combination treatment. It is designed to help position the further research into treatment with T3, which is needed, as a strategic priority for national and international research bodies, who can make it so.  Our hope is that it will also have a positive influence on current clinical practice, giving clinicians confidence about when and how to use T3 appropriately with those patients who require it. 

We will be producing a "lay" report of this event, with the kind support and guidance of Professor Colin Dayan, of Cardiff University, who has generously agreed to lead review our write up, prior to publication, helping us ensure that we report accurately. 

We are committed to improving access to reliable  information that thyroid patients will find useful, both to be informed and to potentially influence their care, by helping them inform their healthcare providers.   This is our aim in attending and reporting on this symposium. 

Wish us luck please! There will be lots of doctors and just a few patient representatives attending. It's going to be an intense learning experience, no doubt, with lots of information to absorb and we hope to also make some new contacts. We will do our best to produce a good report. 

Two patient representatives, based in the US, will be discussing patient experiences of treatment for hypothyroidism in the final session. It will be fascinating to learn how their experiences compare to those of us in the UK.  We are grateful to them for putting themselves forward to represent hypothyroid patients  as a whole. We would, of course, have liked there to be more patient participation and for patients in the UK to be able to have their say, but we recognise it is a global symposium with a lot to cover and a very packed programme over just one day and we trust that this event will generate further opportunities for more patient experiences to be heard and taken seriously. 

See the full programme; and if you are a professional who is interested in attending, details of how to register and the cost, here:  T3/T4 Symposium Details.  

---